Robotic Endoscopy Devices Market: AI-Assisted Colonoscopy, Flexible Robotic GI Endoscopy, and Robotic Bronchoscopy for Peripheral Lung Access to Drive Exceptional Market Growth Through 2035

The global Robotic Endoscopy Devices market was valued at USD 2.6 billion in 2025 and is projected to reach USD 6.0 billion by 2035, advancing at an exceptional CAGR of 9.7%. The market encompasses diagnostic robotic endoscopy devices (robotic diagnostic endoscopes, robotic capsule endoscopy systems, robotic navigation endoscopy systems) and therapeutic robotic endoscopy devices (robotic endoscopic surgery systems, resection systems, suturing and closure systems, biopsy systems, ablation systems). By procedure type: diagnostic, therapeutic, image-guided, and minimally invasive surgical procedures. By application: laparoscopy, bronchoscopy, colonoscopy, upper GI endoscopy, urology, gynaecology, ENT, and neurosurgery. By technology: master-slave robotic systems, magnetically controlled robotic systems, capsule robotic endoscopy, flexible robotic endoscopy systems, AI-assisted robotic endoscopy, and autonomous/semi-autonomous systems. By component: robotic platform, arms, console, navigation system, visualisation system (HD/3D/4K), accessories and instruments, and software and navigation modules. End users: hospitals, ASCs, outpatient facilities, specialty endoscopy centres, and academic and research institutes.

The robotic endoscopy devices market is experiencing exceptional growth at 9.7% CAGR from the convergence of robotic technology with two major endoscopy domains: the commercial deployment of AI-assisted robotic systems for automated polyp detection during colonoscopy — demonstrably improving adenoma detection rates above standard colonoscopy — and the clinical development of flexible robotic bronchoscopy platforms for navigated peripheral lung lesion biopsy that overcomes the fundamental limitation of conventional flexible bronchoscopy in reaching small peripheral pulmonary nodules through tortuous distal bronchial anatomy.

Executive Snapshot

How are AI-assisted robotic colonoscopy systems improving adenoma detection above standard colonoscopy?
Computer-aided detection (CADe) systems that analyse real-time colonoscopy video frames using deep learning object detection algorithms and generate immediate visual alerts to the endoscopist when a polyp-like lesion is identified in the field of view have been evaluated in multiple large randomised controlled trials demonstrating statistically significant adenoma detection rate improvement above standard unassisted colonoscopy, particularly for diminutive and flat polyps below 5 mm in diameter that carry the highest endoscopist miss rates. Meta-analyses aggregating AI-CADe colonoscopy trial data confirm a pooled adenoma detection rate improvement of approximately 10 to 15 absolute percentage points, sustaining commercial deployment of AI-CADe modules as standard of care enhancements at colonoscopy quality-focused programmes.

How do robotic bronchoscopy platforms overcome the peripheral pulmonary nodule biopsy limitation of conventional bronchoscopy?
Robotic bronchoscopy systems — including the Intuitive Ion and Auris Monarch robotic bronchoscope platforms — deliver a steerable robotic catheter with integrated vision and ultrasound or CT-fluoroscopy-based navigation guidance through bronchial airways to sub-segment positions adjacent to peripheral pulmonary nodules below 20 mm in diameter that conventional flexible bronchoscopes cannot reliably navigate. The robotic catheter’s ability to make simultaneous roll, pitch, and yaw movements with constant luminal vision enables navigation to bronchi that human wrist torque applied to a conventional bronchoscope cannot achieve, improving the bronchoscopic biopsy yield for CT-screen-detected peripheral lung lesions above the 30 to 50 percent yield ceiling of standard guided bronchoscopy.

How is magnetically controlled robotic capsule endoscopy advancing above conventional wireless capsule endoscopy?
Magnetically controlled robotic capsule endoscopes — navigated through the GI lumen using external magnet systems controlled by the examining physician from outside the patient body — provide active steering capability that allows the physician to direct the capsule’s view toward mucosal areas of clinical interest, hold the capsule in position for extended mucosal examination, and retroflect to visualise the proximal gastric fundus that passively tumbling conventional wireless capsules rarely image adequately. Magnetically guided capsule gastroscopy has been evaluated as an alternative to conventional upper GI endoscopy in anxiety-averse and unsedated patients, with published feasibility data supporting diagnostic equivalence in cooperative patients.

What is driving therapeutic robotic endoscopy adoption in complex GI procedures?
Therapeutic robotic endoscopy systems providing bimanual instrument control through robotic arms introduced through the working channels of therapeutic endoscopes enable precise tissue manipulation in endoscopic submucosal dissection, endoscopic closure of GI perforations and defects, and per-oral endoscopic myotomy procedures that require the equivalent of two-handed technique that single-instrument conventional endoscopy cannot achieve with comparable precision. Robotic ESD systems maintaining continuous tissue traction while the cutting instrument operates in the submucosal plane dramatically reduce the technical complexity of this demanding procedure, sustaining investment in robotic therapeutic endoscopy despite the significant capital cost of dedicated robotic endoscopy platforms.

What clinical performance advantages do robotic flexible endoscopy systems provide in ERCP?
Robotic catheter systems for ERCP biliary cannulation — providing physician-controlled deflection and rotation of the catheter tip through a robotic handle rather than manual guidewire torque at the endoscope working channel — reduce failed biliary cannulation rates in difficult papilla anatomy cases where conventional guidewire technique is associated with post-ERCP pancreatitis from repeated unsuccessful cannulation attempts. Robotic ERCP catheter systems are evaluated at advanced endoscopy centres managing high volumes of difficult biliary access cases including surgically altered anatomy and periampullary diverticulum that create conventional cannulation technical challenges.

Which robotic endoscopy segments are growing fastest?
AI-CADe colonoscopy system deployment as standard of care enhancement across colonoscopy quality-focused programmes, robotic bronchoscopy peripheral lung nodule biopsy adoption from CT screening programme growth, magnetically controlled capsule endoscopy advancing gastric examination above conventional passive capsule, and therapeutic robotic ESD systems reducing procedural complexity for advanced GI neoplasia resection are the four fastest-growing segments.

Market Dynamics: Robotic Endoscopy Devices Market

  • AI-CADe colonoscopy system deployment sustaining commercial adoption from multiple RCT evidence of ADR improvement across colonoscopy quality programmes.
    AI-CADe colonoscopy adoption sustaining robotic endoscopy device software revenue from RCT-demonstrated ADR improvement sustaining commercial deployment as standard of care enhancement.
  • Robotic bronchoscopy sustaining adoption from CT-screen-detected peripheral lung nodule biopsy market generated by expanding lung cancer screening programme coverage.
    Robotic bronchoscopy adoption sustained from expanding CT lung cancer screening programme-generated peripheral pulmonary nodule biopsy demand above conventional bronchoscopy yield ceiling.
  • Magnetically controlled capsule endoscopy growing from passive capsule gastroscopy limitations in fundus and active mucosal interrogation capability.
    Magnetically controlled robotic capsule adoption growing from active steering capability above passively tumbling conventional wireless capsule in gastric examination and proximal GI inspection.
  • Therapeutic robotic ESD systems sustaining investment at advanced GI endoscopy centres performing complex gastric and colorectal neoplasia resection.
    Therapeutic robotic ESD system adoption sustained at advanced GI endoscopy programmes where bimanual robotic tissue traction reduces ESD procedural complexity and complication risk.
  • Robotic ERCP catheter systems sustaining adoption at advanced endoscopy centres managing difficult biliary access and altered anatomy ERCP cases.
    Robotic ERCP catheter adoption sustained at advanced endoscopy programmes managing high volumes of difficult biliary cannulation cases in surgically altered anatomy.
  • AI integration across all robotic endoscopy platforms sustaining software and analytics subscription revenue above hardware replacement cycles.
    AI software and analytics platform subscription revenue sustaining robotic endoscopy device value above pure hardware replacement cycles at adopting programmes.

Market Segmentation: Robotic Endoscopy Devices Market

By Procedure Type
  • Diagnostic Procedures
  • Therapeutic Procedures
  • Image-Guided Procedures
  • Minimally Invasive Surgical Procedures
By Technology
  • Master-Slave Robotic Systems
  • Magnetically Controlled Robotic Systems
  • Capsule Robotic Endoscopy
  • Flexible Robotic Endoscopy Systems
  • AI-Assisted Robotic Endoscopy Systems
  • Autonomous/Semi-Autonomous Robotic Systems
By Application
  • Laparoscopy
  • Bronchoscopy
  • Colonoscopy
  • Gastrointestinal Endoscopy (Upper GI)
  • Urology
  • Gynecology
  • ENT Endoscopy
  • Neurosurgery
  • Other Applications
By Product Type
  • Diagnostic Robotic Endoscopy Devices
    • Robotic Diagnostic Endoscopes
    • Robotic Capsule Endoscopy Systems
    • Robotic Navigation Endoscopy Systems
  • Therapeutic Robotic Endoscopy Devices
    • Robotic Endoscopic Surgery Systems
    • Robotic Endoscopic Resection Systems
    • Robotic Endoscopic Suturing & Closure Systems
    • Robotic Biopsy Systems
    • Robotic Endoscopic Ablation Systems
    • Other Therapeutic Robotic Endoscopy Devices
By Component
  • Robotic Platform
    • Robotic Arms
    • Robotic Console
    • Navigation System
  • Visualization System
    • HD Imaging
    • 3D Imaging
    • 4K Imaging
  • Accessories & Instruments
    • Robotic Endoscopes
    • Endoscopic Instruments
    • Disposable Accessories
    • Software & Navigation Modules
By End User
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Outpatient Facilities
  • Specialty Endoscopy Centers
  • Academic & Research Institutes
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Robotic Endoscopy Devices Market

  1. AI-CADe colonoscopy RCT evidence sustaining commercial deployment as standard of care enhancement at colonoscopy quality programmes.
    AI-CADe colonoscopy system adoption sustained by multiple RCT ADR improvement evidence sustaining commercial deployment at colonoscopy quality-focused screening and diagnostic programmes.
  2. Robotic bronchoscopy peripheral lung nodule biopsy adoption from expanding CT lung cancer screening programme coverage.
    Robotic bronchoscopy adoption sustained from CT screening-detected peripheral pulmonary nodule biopsy demand above conventional flexible bronchoscopy yield ceiling.
  3. Magnetically controlled capsule gastroscopy advancing above passive capsule from active steering and fundus visualisation capability.
    Magnetically controlled capsule endoscopy growing from active steering capability enabling fundus examination and mucosal interrogation above conventional passive wireless capsule.
  4. Therapeutic robotic ESD system adoption reducing procedural complexity at advanced GI endoscopy centres.
    Therapeutic robotic ESD system adoption sustained at GI endoscopy centres where bimanual robotic tissue control reduces ESD procedural complexity and perforation risk.
  5. Robotic ERCP catheter adoption at advanced endoscopy centres managing difficult biliary access cases.
    Robotic ERCP catheter adoption sustained at advanced endoscopy programmes managing surgically altered anatomy and difficult papilla cannulation cases.
  6. AI integration sustaining software subscription revenue above hardware replacement cycles at adopting robotic endoscopy programmes.
    AI software and analytics subscription revenue sustaining robotic endoscopy platform value above pure hardware replacement at colonoscopy and bronchoscopy adopting programmes.

Regional Outlook: Robotic Endoscopy Devices Market

  • North America: The largest robotic endoscopy market, driven by strong AI-CADe colonoscopy commercial deployment following FDA clearance of multiple AI polyp detection systems, rapid robotic bronchoscopy adoption at U.S. academic pulmonary medicine and thoracic surgery programmes managing CT screen-detected lung nodules, and therapeutic robotic endoscopy development at academic GI endoscopy research centres.
  • Europe: Germany, France, the UK, and Italy anchor European robotic endoscopy demand. EU MDR regulatory pathways for AI-CADe software as a medical device and robotic endoscopy system certification are shaping commercial deployment timelines and evidence requirements. Magnetically controlled capsule endoscopy has been particularly adopted at European gastroenterology centres offering unsedated patient-preferred gastric examination alternatives.
  • Asia-Pacific: The fastest-growing regional robotic endoscopy market, driven by Japan’s world-leading endoscopic disease detection sophistication, China’s large colonoscopy programme volume sustaining AI-CADe adoption, South Korea’s advanced robotic surgery capabilities at university hospital programmes, and academic GI endoscopy research investment in therapeutic robotic ESD systems at Japanese and Chinese advanced endoscopy centres.

Competitive Landscape: Robotic Endoscopy Devices Market

Key Players: Intuitive Surgical (Ion Robotic Bronchoscopy), Johnson & Johnson (Monarch/Auris), Medtronic (Hugo Robot), Olympus (EndoBRAIN AI, Endoscopy AI), Fujifilm (CAD EYE AI Colonoscopy), AI Medical Service (Gastrointestinal AI), Endomag (AI Localization), Activ Surgical, Motus GI Holdings (Pure-Vu), Endorobotics (Robotic Colonoscopy), Endomagnetics, Magnetically Controlled Endoscopy, Aesthetics and Advanced Endoscopy, Pentax Medical (AI Integration), Boston Scientific (Robotic Endoscopy), EndoGastric Solutions, Apollo Endosurgery (Robotic Bariatric), Stryker (Robotic Integration)

  • Olympus Corporation confirmed commercial launch of its EndoBRAIN AI polyp detection system as an FDA-cleared CADe module for colonoscopy at U.S. and Japanese gastroenterology programmes, reporting that EndoBRAIN integration into Olympus EVIS X1 colonoscopy systems provides real-time polyp detection alerts with sensitivity and specificity validated in multi-centre randomised trials, and that U.S. commercial deployment at major colonoscopy screening programmes is sustaining ADR improvement documentation in real-world colonoscopy quality registries that support broader adoption discussions at health systems implementing systematic colonoscopy quality improvement programmes.
  • Intuitive Surgical reported continued robotic bronchoscopy procedure volume growth with its Ion platform at U.S. academic medical centres and growing community hospital pulmonary medicine programmes managing CT-screen-detected peripheral pulmonary nodules, with Intuitive citing a post-market registry study demonstrating Ion procedure diagnostic yield exceeding 75 percent for peripheral lesions below 20 mm in diameter — approximately doubling the 35 to 50 percent yield of guided conventional bronchoscopy for similar lesion size categories — sustaining physician confidence in Ion robotic bronchoscopy as the preferred bronchoscopic approach for small peripheral nodule diagnosis.
  • Fujifilm Medical confirmed commercial availability of its CAD EYE artificial intelligence colonoscopy detection and characterisation system at European and Asia-Pacific gastroenterology programmes following CE mark certification as a class IIa software medical device, with Fujifilm reporting that CAD EYE’s dual CADe (detection) and CADx (characterisation) functionality enables both polyp detection alerting and real-time optical diagnosis classification of detected polyps as adenomatous or hyperplastic, providing a combined workflow that reduces unnecessary polypectomy of non-adenomatous polyps while sustaining high adenoma detection sensitivity.

Consultant POV

The Robotic Endoscopy Devices market exceptional trajectory toward USD 6.0 billion by 2035 at 9.7% CAGR reflects the convergence of AI-CADe colonoscopy RCT evidence sustaining commercial deployment, robotic bronchoscopy peripheral lung biopsy adoption, and therapeutic robotic endoscopy advancing complex GI procedure capability. Olympus EndoBRAIN AI colonoscopy commercial launch, Intuitive Surgical Ion robotic bronchoscopy registry yield data, and Fujifilm CAD EYE dual CADe/CADx European commercialisation confirm the robotic endoscopy devices market will sustain exceptional above-sector growth through 2035.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC